Topics

Hips

2:22 a.m. April 17, 2020 - By Jaimy Lee
Johnson & Johnson execs offer upbeat view of second-half recovery from COVID-19 pandemic Here’s how Johnson & Johnson expects the pandemic to impact its 2020 performance: first quarter (initial impact), second quarter (significant impact), third quarter (stabilization), and fourth quarter (recovery)Johnson & Johnson executives had a surprisingly rosy take about an economic recovery in the second half of the year even as the COVID-19 pandemic cratered the company’s $25 billion medical device business in the first quarter of 2020.
Browse topics:

Filter results by

Location

Us (5)

Link to MarketWatch's Slice.